Accelerating Healthcare & Life Sciences Innovation
from Discovery to Deployment.​

A premier New York City platform for digital health, AI, medtech, diagnostics, biotech and life sciences innovators entering or scaling in the U.S. market.​

About HITLAB

An evidence-first launchpad, proven since 1998​

For 25+ years, HITLAB’s rigorous, independent research has made health technologies U.S.-ready.​

  • Evidence made U.S.- ready​

    We prepare each innovation's clinical and economic evidence to stand up to the scrutiny of U.S. payers, providers and regulators.

  • Pathways that open doors​

    HITLAB communications channels and networks unlock new business, alliances, venture capital and grant funding.​

  • Impact at national scale​

    The mission: move breakthrough technologies into U.S. care to improve the lives of 350 million Americans.​

Two Decades of Independent Proof

650+ validation studies conducted over 20+ years, with no investment stake, from our New York City base — the credibility U.S. stakeholders trust.​

Navigating The US Market

From Evidence to Adoption

We help non-U.S. innovators decode the ecosystem, clear regulatory and reimbursement hurdles, and prove their
platform through real-world pilots.​

  • U.S. healthcare ecosystem​

    Map the stakeholders, buyers and care settings that decide whether a technology is adopted.​

  • Reimbursement pathways​

    Identify the coding, coverage and payment routes that make the economics work for U.S. payers.​

  • FDA & CMS strategy​

    Navigate FDA and CMS regulatory pathways and align to the resources each milestone demands.​

  • Pilot site relationships​

    Develop relationships with U.S. pilot sites and health systems ready to test and adopt.​

  • IRB & study execution​

    Lead IRB protocol development, approval and pilot study execution with clinical-research rigor.​

  • Adoption & alignment​

    Align to U.S. customer expectations and drive platform adoption across the health system.​

One evidence-first pathway — from U.S. market entry to system-wide adoption.​

Why HealthTech Launchpad USA​

A focused commercialization engine for healthcare and life sciences innovators seeking U.S. traction.​

  • Launch faster​

    Clarify product-market fit, commercialization strategy and early customer pathways.​

  • Validate smarter​

    Design pilots, outcomes frameworks and evidence-generation plans for adoption.​

  • Scale strategically​

    Connect to the right health systems, pharma, payers, employers, investors and technology partners.​

NYC As a Launch Point

Position innovators at the center of one of the world’s most dynamic healthcare, life sciences, technology and investment ecosystems.​

Who We Serve

Built for innovators across healthcare and life sciences​

A cohort experience designed for founders, researchers and growth-stage teams ready to move from promise to proof.​

  • Digital health startups​

    Care delivery, access, engagement, remote care and population health,etc

  • AI + analytics companies​

    Clinical, operational, workflow and data-driven solutions.​

  • MedTech + devices​

    Connected devices, diagnostics, wearables and regulated products.​

  • Biotech + therapeutics​

    R&D platforms, precision medicine and life sciences innovation.​

  • Academic spinouts​

    Translational research teams moving toward commercialization.​

  • International companies​

    Non-U.S. innovators seeking traction in the U.S. market.​

  • Health system teams​

    Innovation groups looking to validate or partner around solutions.​

  • Growth Stage Ventures

    Companies preparing for customers, investors or strategic partners.​

Program Model
A five-part parallel acceleration pathway​
  • 1. Commercialization Strategy

    Market assessment, competitive positioning, business model and pricing/reimbursement guidance.​

  • 2. Clinical Validation

    Pilot design, research collaborations, outcomes measures and real-world evidence planning.​

  • 3. Strategic Partnerships

    Curated access to providers, pharma, payers, employers, technology and research partners.​

  • 4. Investment Readiness

    Pitch refinement, capital strategy, due diligence preparation and investor introductions.​

  • 5. U.S. Market Entry

    Stakeholder mapping, regulatory navigation, U.S. business strategy and partnership development.​

The outcome: a practical, partner-ready commercialization roadmap with evidence priorities and clear next steps.​

What Participants Receive

Hands-on support across the moments that matter​

Every company receives targeted guidance, curated introductions and market-facing assets.​

  • Strategy Sprint

    Positioning, messaging, market segment prioritization and commercialization roadmap.​

  • Pilot + Evidence Design

    Study questions, deployment model, outcomes framework and partner-ready pilot package.​

  • Mentor Office Hours

    Clinicians, investors, life sciences executives, operators and commercialization experts.​

  • Partner Matchmaking

    Curated introductions to health systems, pharma, payers, employers, tech and research partners.​

  • Pitch + Investor Prep

    Pitch narrative, data room expectations, funding pathway and diligence readiness.​

  • Showcase Visibility

    Cohort demo day, innovation showcase, executive roundtable access and market exposure.​

Validation

Clinical validation​ & evidence generation​

Healthcare adoption requires more than a compelling product. Participants learn how to generate credible proof, define outcomes and structure pilots for enterprise buyers and clinical partners.​

  • Pilot Design

    Define setting, users, workflows and endpoints.​

  • Research Collaboration

    Align stakeholders around study design and operational needs.​

  • Outcomes Measurement

    Identify metrics that matter to clinical, economic and operational decision-makers.​

  • Real World Evidence

    Convert deployments into partner-ready proof points.​

Ecosystem

Curated access to the people who accelerate adoption​

HealthTech Launchpad USA connects participants to the stakeholders needed to commercialize, validate,fund and scale.​

  • Health Systems

  • Pharma + Life Sciences​

  • Payers + Employers​

  • Investors​

  • Technology Partners​

  • Academic + Research​

U.S. Market Entry

A soft landing for global health innovators​

For international companies, the program creates a practical path to U.S. stakeholders, pilots, partners and market learning.​

  • Map

    U.S. buyer and stakeholder landscape​

  • Adapt

    Go-to-market, messaging and validation priorities​

  • Connect

    Curated introductions to partners and advisors​

  • Launch

    Pilot, evidence and commercial next steps​

New York City as your launchpad

Program Outcomes

Participants leave with assets that move the business forward​

Clear, tangible outputs designed to support adoption, fundraising, partnerships and revenue growth.​

  • Commercialization Roadmap

    A prioritized pathway for target markets, buyers and near-term execution.​

  • Partner Ready Story

    Sharper narrative, value proposition and use- case framing for enterprise stakeholders.​

  • Pilot Packaging

    A practical pilot concept with success metrics, deployment considerations and evidence goals.​

  • Curated Introductions

    Meaningful connections to potential customers, strategic partners, advisors and investors.​

  • Investment Readiness

    Improved pitch materials, diligence preparation and capital strategy.​

  • Market Visibility

    Showcase exposure across healthcare, life sciences and innovation audiences.​

The goal: shorten the path from promising innovation to healthcare impact.​

Case Studies

Proven across the HITLAB network​

A snapshot of health innovators HITLAB has helped validate, credential and scale in the U.S. market.​

Smart biometric garments​ (Canada)​

Smart crutch rehabilitation​ (Ukraine)​

AI ECG heart monitoring​ (Czechia)​

AI clinical navigation​ (Israel)​

AR-guided telepresence​ (Canada)​

Affordable telemedicine​ (India)​

Digital engineering solutions​ (Germany)​

Healthcare AI and data solutions​ (India)​

Medication engagement​ (Israel)​

Join the Next Cohort

Transform innovation into healthcare impact

  • Apply

    For founders, spinouts and growth-stage teams ready to accelerate.​

  • Partner

    For health systems, pharma, payers, employers, investors and technology partners.​

  • Sponsor

    For organizations seeking visibility with high- potential healthcare innovators.​

Plan Your Liftoff

Get in touch with us to begin your journey